Anúncio
Anúncio

GILD

GILD logo

Gilead Sciences Inc

121.36
USD
Patrocinado
+3.07
+2.60%
06 de jan., 15:59 UTC -5
Encerrado
exchange

Pré-Mercado

121.39

+0.03
+0.03%

Relatórios de Lucros GILD

Rácio de surpresa positiva

GILD separação 24 de 39 últimas estimativas.

62%

Próximo Relatório

Data do Próximo Relatório
09 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$7.81B
/
$1.89
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+0.51%
/
-23.48%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+3.16%
/
-0.53%

Gilead Sciences Inc earnings per share and revenue

On 30 de out. de 2025, GILD reported earnings of 2.47 USD per share (EPS) for Q3 25, beating the estimate of 2.17 USD, resulting in a 13.68% surprise. Revenue reached 7.77 bilhão, compared to an expected 7.60 bilhão, with a 2.29% difference. The market reacted with a +1.14% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 21 analistas forecast an EPS of 1.89 USD, with revenue projected to reach 7.81 bilhão USD, implying an diminuir of -23.48% EPS, and aumentar of 0.51% in Revenue from the last quarter.
FAQ
For Q3 2025, Gilead Sciences Inc reported EPS of $2.47, beating estimates by 13.68%, and revenue of $7.77B, 2.29% above expectations.
The stock price moved up 1.14%, changed from $118.44 before the earnings release to $119.79 the day after.
The next earning report is scheduled for 09 de fev. de 2026.
Based on 21 analistas, Gilead Sciences Inc is expected to report EPS of $1.89 and revenue of $7.81B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio